Roche
ROG.SW
$265.21
Share price
-0.97%
Change (1 day)
-18.84%
Change (1 year)
Categories
Roche (ROG.SW) - Net assets
Net assets on the balance sheet as of June 2023 : $33.74 B
According to Roche's latest financial reports the company has $33.74 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Roche - Net assets on balance sheet (from 2006 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $34.65 B | 11.71% |
| 2021-12-31 | $31.02 B | -31.24% |
| 2020-12-31 | $45.11 B | 21.84% |
| 2019-12-31 | $37.02 B | 19.94% |
| 2018-12-31 | $30.87 B | 3.63% |
| 2017-12-31 | $29.78 B | 14.94% |
| 2016-12-31 | $25.91 B | 9.9% |
| 2015-12-31 | $23.58 B | 8.14% |
| 2014-12-31 | $21.80 B | -8.91% |
| 2013-12-31 | $23.94 B | 30.61% |
| 2012-12-31 | $18.33 B | 18.74% |
| 2011-12-31 | $15.43 B | 23.7% |
| 2010-12-31 | $12.47 B | 37.1% |
| 2009-12-31 | $9.10 B | -82.36% |
| 2008-12-31 | $51.60 B | 9.59% |
| 2007-12-31 | $47.09 B | 22.38% |
| 2006-12-31 | $38.47 B | 21.29% |
| 2005-12-31 | $31.72 B | 8.68% |
| 2004-12-31 | $29.19 B | 23.78% |
| 2003-12-31 | $23.58 B | -15.83% |
| 2002-12-31 | $28.01 B | -23.9% |
| 2001-12-31 | $36.81 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $76.40 B | 126.41% | 🇺🇸 USA |
 Novartis NVS | $51.93 B | 53.88% | 🇨🇭 Switzerland |
 Pfizer PFE | $99.29 B | 194.22% | 🇺🇸 USA |
 Abbott Laboratories ABT | $37.40 B | 10.83% | 🇺🇸 USA |
 Amgen AMGN | $6.78 B | -79.91% | 🇺🇸 USA |
 Sanofi SNY | $79.27 B | 134.92% | 🇫🇷 France |
 Becton Dickinson BDX | $25.93 B | -23.14% | 🇺🇸 USA |
 Merck MRK | $38.74 B | 14.80% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.33 B | -54.55% | 🇬🇧 UK |